Impact of percutaneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

“…Searches were limited to studies conducted in human subjects and reviews and other evidence pertaining to human subjects; all were published in English. Key [5][6][7] Particular emphasis is placed on advances in reperfusion therapy, organization of regional systems of care, transfer algorithms, evidence-based antithrombotic and medical therapies, and secondary prevention strategies to optimize patient-centered care. By design, the document is narrower in scope than the 2004 STEMI Guideline, in an attempt to provide a more focused tool for practitioners.…”

Impact of Percutaneous Coronary Intervention Performance Reporting on Cardiac Resuscitation Centers

“…Accumulating clinical data now show that up to 70% of OHCA patients have coronary artery disease, and nearly half have an acute coronary occlusion. [4][5][6][7][8][9][10][11][12][13][14][15][16][17][18] These data underscore the importance of early coronary angiography, and reperfusion in these patients is likely similar to that in STEMI patients who have not had a CA.…”

“…13 This 50% survival is double the previous long-term survival rate before such aggressive bundled postarrest care was used. 13 Such an aggressive postarrest revascularization approach [5][6][7][8][9][10][12][13][14][15][16][17][18][19][20][21] has the unintended consequence of causing the centers that perform the type of highvolume, quality postarrest care that follows a Class I AHA guideline to have significantly higher mortality than hospitals that treat only a few postarrest patients annually. Appropriate subsets of postarrest patients being given immediate access to the catheterization laboratory involves treating many patients who will ultimately succumb to neurological or multiorgan failure rather than a cardiovascular death, 22 yet their deaths are reported simultaneously with all other STEMI patients, the majority of whom have a 10-fold lower periprocedural mortality.…”

Guía sobre el manejo de la angina estable. Versión resumida

“…Sin embargo, la angiografía podría estar contraindicada por incapacidad o comorbilidad seria, y también puede ofrecer resultados no concluyentes. Tras una parada cardiaca con reanimación o una arritmia ventricular potencialmente mortal, el diagnóstico definitivo de presencia o ausencia de enfermedad coronaria es muy útil a la hora de tomar decisiones clínicas 68,69 . Además, las pruebas no invasivas no permiten valorar si es posible realizar una revascularización coronaria, que podría plantearse tanto para tratar los síntomas como para mejorar el pronóstico.…”